Skip to main content
BrainCited

Vitamin E para Age-Related Cognitive Decline

C

High-dose vitamin E may slow functional decline in moderate Alzheimer's disease (TEAM-AD trial). Results are mixed for cognitive decline prevention in healthy populations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dvitamin\u002De\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Conclusión

High-dose vitamin E may slow functional decline in moderate Alzheimer's disease (TEAM-AD trial). Results are mixed for cognitive decline prevention in healthy populations.

Key Study Findings

Systematic Review n=80488
Vitamin E and cognitive function: A systematic review of clinical evidence.
Dose: None vs: None Outcome: cognitive function / cognitive impairment Efecto: None None

Población: participants from 43 clinical studies (2012-2022)

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD Efecto: None None

Población: Alzheimer's disease patients

Observational Study n=2713 Open-label
Non-linear association between dietary fiber intake and cognitive function mediated by vitamin E: a cross-sectional …
Dose: Inflection at 29.65 g/day (DSST), 22.65 g/day (composite) vs: Cross-sectional fiber intake groups Outcome: Cognitive function composite z-scores (DSST, AFT, CERAD) Efecto: β=0.18 per unit fiber below inflection <0.0001

Población: NHANES adults aged ≥60 years (2011-2014)

Review
The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic …
Dose: None vs: None Outcome: None Efecto: None None

Población: Review of vitamins in neurodegeneration

Review
Bioactive compounds and dietary patterns in Alzheimer's disease.
Dose: None vs: None Outcome: AD progression and cognitive decline Efecto: None None

Población: Elderly with or at risk of Alzheimer's disease (review)

Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None vs: Standard care or placebo Outcome: Global cognition in stroke survivors Efecto: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins) 0.009 (protein); 0.02 (B-vit)

Población: Adult stroke survivors (20 trials + 14 observational)

Key Statistics

12

Estudios

3000

Participantes

Mixed

C

Calificación

Referenced Papers

Journal of Alzheimer's … 2025 3 citas
American journal of … 2025
European geriatric medicine 2023 10 citas
Nutrients 2022 76 citas
Plant foods for … 2013 155 citas
Orphanet journal of … 2011 158 citas
American family physician 2011
Clinica chimica acta; … 2006 134 citas
Archives of neurology 2002 354 citas
The Proceedings of … 2002 191 citas
Asia Pacific journal … 2002 24 citas
Current opinion in … 1998 30 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
15 mg/day (RDA)
cognitivesupport:
400-800 IU/day

Límite superior: 1,000 mg/day (1,500 IU natural / 1,100 IU synthetic)

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive 80488
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
Inflection at 29.65 g/day (DSST), 22.65 g/day (composite) -- Positive 2713
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --

Mejor momento para tomar: With meals containing fat

Safety & Side Effects

Efectos secundarios reportados

  • Increased bleeding risk at high doses
  • Nausea and diarrhea
  • Fatigue and weakness
  • Blurred vision

Interacciones conocidas

  • Anticoagulants (increased bleeding risk)
  • Statins and niacin (may reduce HDL-raising effects)
  • Chemotherapy and radiation (may reduce efficacy)

Ingesta máxima tolerable: 1,000 mg/day (1,500 IU natural / 1,100 IU synthetic)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Vitamin E help with Age-Related Cognitive Decline?
Based on 12 studies with 3,000 participants, there is limited but promising evidence that Vitamin E may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Vitamin E should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 15 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin E?
Reported side effects may include Increased bleeding risk at high doses, Nausea and diarrhea, Fatigue and weakness, Blurred vision. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin E and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 12 peer-reviewed studies with 3,000 total participants. The overall direction of effect is mixed.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.